Pemazyre

(pemigatinib)
pemigatinib 13.5 MG Oral Tablet [Pemazyre]pemigatinib 4.5 MG Oral Tablet [Pemazyre]
View 1 more
NO BLACK BOX WARNING

Dosage & administration

Cholangiocarcinoma:

Myeloid/lymphoid neoplasms with FGFR1 rearrangement:


All patients treated with PEMAZYRE:


drug label

Pemazyre prescribing information

Have more Pemazyre questions?

Submit MSL Request
Learn More

Need to report a Pemazyre issue?

ONLINE FORM
Report adverse event
Learn More

samples

Request Pemazyre samples

NOT PROVIDED BY BRAND
View Online Sample Form
Learn More

prior authorization

Pemazyre Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request
Coverage Authorization Appeals
Learn More

Benefits investigation

IncyteCARES for Pemazyre Enrollment Form
IncyteCARES for Pemazyre Enrollment Form - Online
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Pemazyre Financial assistance options

Co-pay savings program

commercial only
IncyteCARES for Pemazyre Enrollment Form
IncyteCARES for Pemazyre Enrollment Form - Online
Enroll in Patient Savings Program - HCP Office
Enroll in Patient Savings Program - Patient
Learn More

Bridge program

commercial only
IncyteCARES for Pemazyre Enrollment Form
IncyteCARES for Pemazyre Enrollment Form - Online
IncyteCARES for Pemazyre Temporary Access Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
IncyteCARES for Pemazyre Enrollment Form
IncyteCARES for Pemazyre Enrollment Form - Online
IncyteCARES for Pemazyre Patient Assistance Program
Learn More

patient education

Pemazyre Patient education

Getting started on Pemazyre

NOT PROVIDED BY BRAND
Instructions For Use: Metastatic Cholangiocarcinoma with FGFR2 Fusion

NOT PROVIDED BY BRAND
Instructions For Use: Myeloid/Lymphoid Neoplasms

Patient toolkit

About Pemazyre: Metastatic Cholangiocarcinoma with FGFR2 Fusion
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Pemazyre: Metastatic Cholangiocarcinoma with FGFR2 Fusion
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effect Discussion Guide: Metastatic Cholangiocarcinoma with FGFR2 Fusion
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Metastatic Cholangiocarcinoma with FGFR2 Fusion
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Treatment Tracker
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.